Michelle A. Yue-Seng
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial.
Journal: Nature communications
Published: November 20, 2024
Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.
Journal: Cancer research
Published: September 12, 2024
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.
Journal: NPJ precision oncology
Published: August 04, 2024
Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features.
Journal: Nature cancer
Published: December 24, 2023
SINGLE CELL DISSECTION OF DEVELOPMENTAL ORIGINS AND TRANSCRIPTIONAL HETEROGENEITY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.
Journal: bioRxiv : the preprint server for biology
Published: December 18, 2023
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.
Journal: Cell reports
Published: April 11, 2023
Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia.
Journal: Nature genetics
Published: July 13, 2022
A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genome.
Journal: Leukemia
Published: June 01, 2022
TFEB-mediated endolysosomal activity controls human hematopoietic stem cell fate.
Journal: Cell stem cell
Published: April 22, 2021
Last Updated: 09/26/2026